Search This Blog
Magna Wave Blog Mission
Magna Wave is on the cutting edge of Pulsed Electro-magnetic Field technology (PEMF). Designed to balance, rejuvenate, and replenish diminished cellular integrity.
Friday, September 3, 2010
John Chance Lifewave Equine Applications
Thursday, August 12, 2010
Doctor turns chiropractic care toward animals
Wednesday, July 28, 2010
In search of increased energy and endurance?
I think you will enjoy this video demonstration at Florida State University.
Ali Nilforushan, Champion Rider, talks about Magna Wave
Tuesday, July 27, 2010
Magna Wave and Gout.
Mary Jo Trotter, Hey Pat! I've used the Magna Wave on my husband the last two times he felt his gout coming on - got to get it early. First time it "steered it off" and he hardly got anything, this last time (we were...vacationing) it helped about 90%. BUT he also continued to have a few brews. 2 days later he was playing tennis! Anyone else using it for this?? If not, should be!!!!! Forgot to add, that was with NO medication.
Friday, July 23, 2010
Magna Wave Human Applications
Create your own video slideshow at animoto.com.
Thursday, July 22, 2010
Gary Young talks about Magna Wave
Tuesday, July 20, 2010
Monday, July 19, 2010
Friday, July 16, 2010
Wednesday, July 14, 2010
Sensitivity to Magna Wave sessions.
Monday, July 12, 2010
It’s easier and quicker to move an ion than to rebuild a tissue.
Saturday, May 8, 2010
The Effect of Pulsed Electromagnetic Fields in the Treatment of Osteoarthritis of the Knee and Cervical Spine.
OBJECTIVE. We conducted a randomized, double blind clinical trial to determine the effectiveness of pulsed electromagnetic fields (PEMF) in the treatment of osteoarthritis (OA) of the knee and cervical spine. METHODS. A controlled trial of 18 half-hour active or placebo treatments was conducted in 86 patients with OA of the knee and 81 patients with OA of the cervical spine, in which pain was evaluated using a 10 cm visual analog scale, activities of daily living using a series of questions (answered by the patient as never, sometimes, most of the time, or always), pain on passive motion (recorded as none, slight, moderate, or severe), and joint tenderness (recorded using a modified Ritchie scale). Global evaluations of improvement were made by the patient and examining physician. Evaluations were made at baseline, midway, end of treatment, and one month after completion of treatment. RESULTS. Matched pair t tests showed extremely significant changes from baseline for the treated patients in both knee and cervical spine studies at the end of treatment and the one month follow-up observations, whereas the changes in the placebo patients showed lesser degrees of significance at the end of treatment, and had lost significance for most variables at the one month follow-up. Means of the treated group of patients with OA of the knee showed greater improvement from baseline values than the placebo group by the end of treatment and at the one month follow-up observation. Using the 2-tailed t test, at the end of treatment the differences in the means of the 2 groups reached statistical significance for pain, pain on motion, and both the patient overall assessment and the physician global assessment. The means of the treated patients with OA of the cervical spine showed greater improvement from baseline than the placebo group for most variables at the end of treatment and one month follow-up observations; these differences reached statistical significance at one or more observation points for pain, pain on motion, and tenderness. CONCLUSION. PEMF has therapeutic benefit in painful OA of the knee or cervical spine.
Trock D. et.al. Department of Medicine, Danbury Hospital, CT. J. of Rheumatology